Yongcong N. Yan
107 West Yan Jiang Road
Guangzhou, 510120, China
Guangzhou, 510120, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 37 publications
A radiomic model for noninvasive prediction of PD-L1 and VETC expression in hepatocellular carcinoma using enhanced abdominal CT.
Journal: Frontiers in oncology
Published: August 31, 2025
Fluorescence-guided laparoscopic resection of liver segment 4 plus the right anterior ventral section for hepatocellular carcinoma adjacent to the left hepatic pedicle and middle hepatic vein: a case report.
Journal: Journal of gastrointestinal oncology
Published: August 12, 2025
m6A-Modified circRAPGEF1 Interaction with IGF2BP3 Promotes Hepatocellular Carcinoma Progression via Reprogramming Aspartate Metabolism.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: February 28, 2025
A case of chronic hepatitis B with a high viral load treated with tenofovir amibufenamide
Journal: Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology
Published: February 19, 2025
A deep learning-based clinical-radiomics model predicting the treatment response of immune checkpoint inhibitors (ICIs)-based conversion therapy in potentially convertible hepatocelluar carcinoma patients: a tumor marker prognostic study.
Journal: International journal of surgery (London, England)
Published: December 18, 2024
March5-mediated Trim28 degradation preserves islet β-cell function in mice.
Journal: Nature communications
Published: November 30, 2024
Integrated analysis reveals an immune evasion prognostic signature for predicting the overall survival in patients with hepatocellular carcinoma.
Journal: Cancer cell international
Published: November 25, 2024
Multi-omics analysis identifies OSGEPL1 as an oncogene in hepatocellular carcinoma.
Journal: Discover oncology
Published: November 14, 2024
Integrated analysis reveals an aspartate metabolism-related gene signature for predicting the overall survival in patients with hepatocellular carcinoma.
Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico
Published: January 27, 2024
Comparison of survival benefit and safety between surgery following conversion therapy versus surgery alone in patients with surgically resectable hepatocellular carcinoma at CNLC IIb/IIIa stage: a propensity score matching study.
Journal: International journal of surgery (London, England)
Published: November 25, 2023
Hepatitis B Virus X Protein Represses Expression of Tumor Suppressor PTPN18 in Hepatocellular Carcinoma.
Journal: Molecular cancer research : MCR
Published: August 28, 2023
Last Updated: 09/26/2026